Events

New European Bauhaus Festival 2024
APR
Tue
09
APR
Wed
10
APR
Thu
11
APR
Fri
12
APR
Sat
13

This was 1 year ago

Location

Brussels

Programmes
Culture and society Climate, Energy, Mobility New European Bauhaus

The European Commission is organizing the second edition of the New European Bauhaus Festival on 9-14 April 2024 in Brussels.

The Festival aims to bring together people from all layers of the society to discuss and debate on how we can shape a more sustainable, inclusive and beautiful way of living and future.

The Festival will consist of different events and activities. Check the New European Bauhaus page for more updates on the Festival, programme and registration.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.